These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 20450491)

  • 41. Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship.
    Murias M; Handler N; Erker T; Pleban K; Ecker G; Saiko P; Szekeres T; Jäger W
    Bioorg Med Chem; 2004 Nov; 12(21):5571-8. PubMed ID: 15465334
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanism of human SIRT1 activation by resveratrol.
    Borra MT; Smith BC; Denu JM
    J Biol Chem; 2005 Apr; 280(17):17187-95. PubMed ID: 15749705
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dietary resveratrol prevents development of high-grade prostatic intraepithelial neoplastic lesions: involvement of SIRT1/S6K axis.
    Li G; Rivas P; Bedolla R; Thapa D; Reddick RL; Ghosh R; Kumar AP
    Cancer Prev Res (Phila); 2013 Jan; 6(1):27-39. PubMed ID: 23248098
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis of 2-methyl-3-indolylacetic derivatives as anti-inflammatory agents that inhibit preferentially cyclooxygenase 1 without gastric damage.
    Perissutti E; Fiorino F; Renner C; Severino B; Roviezzo F; Sautebin L; Rossi A; Cirino G; Santagada V; Caliendo G
    J Med Chem; 2006 Dec; 49(26):7774-80. PubMed ID: 17181159
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis, in vitro and in vivo biological evaluation, COX-1/2 inhibition and molecular docking study of indole-N-acylhydrazone derivatives.
    Moraes ADTO; Miranda MDS; Jacob ÍTT; Amorim CADC; Moura RO; Silva SÂSD; Soares MBP; Almeida SMV; Souza TRCL; Oliveira JF; Silva TGD; Melo CML; Moreira DRM; Lima MDCA
    Bioorg Med Chem; 2018 Nov; 26(20):5388-5396. PubMed ID: 30293795
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cancer chemopreventive activity of resveratrol.
    Jang M; Pezzuto JM
    Drugs Exp Clin Res; 1999; 25(2-3):65-77. PubMed ID: 10370867
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 'Bridged' stilbene derivatives as selective cyclooxygenase-1 inhibitors.
    Handler N; Brunhofer G; Studenik C; Leisser K; Jaeger W; Parth S; Erker T
    Bioorg Med Chem; 2007 Sep; 15(18):6109-18. PubMed ID: 17604631
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and biological evaluation of some novel resveratrol amide derivatives as potential anti-tumor agents.
    Yao RS; Lu XQ; Guan QX; Zheng L; Lu X; Ruan BF
    Eur J Med Chem; 2013 Apr; 62():222-31. PubMed ID: 23353741
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recent advances in the study on resveratrol.
    Nakata R; Takahashi S; Inoue H
    Biol Pharm Bull; 2012; 35(3):273-9. PubMed ID: 22382311
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mechanistic insights into cyclooxygenase irreversible inactivation by aspirin.
    Tosco P; Lazzarato L
    ChemMedChem; 2009 Jun; 4(6):939-45. PubMed ID: 19301318
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Resveratrol inhibits LPS-induced MAPKs activation via activation of the phosphatidylinositol 3-kinase pathway in murine RAW 264.7 macrophage cells.
    Zong Y; Sun L; Liu B; Deng YS; Zhan D; Chen YL; He Y; Liu J; Zhang ZJ; Sun J; Lu D
    PLoS One; 2012; 7(8):e44107. PubMed ID: 22952890
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention.
    Ornelas A; Zacharias-Millward N; Menter DG; Davis JS; Lichtenberger L; Hawke D; Hawk E; Vilar E; Bhattacharya P; Millward S
    Cancer Metastasis Rev; 2017 Jun; 36(2):289-303. PubMed ID: 28762014
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ruthenium(ii) arene NSAID complexes: inhibition of cyclooxygenase and antiproliferative activity against cancer cell lines.
    Mandal P; Kundu BK; Vyas K; Sabu V; Helen A; Dhankhar SS; Nagaraja CM; Bhattacherjee D; Bhabak KP; Mukhopadhyay S
    Dalton Trans; 2018 Jan; 47(2):517-527. PubMed ID: 29235601
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Resveratrol and caloric restriction prevent hepatic steatosis by regulating SIRT1-autophagy pathway and alleviating endoplasmic reticulum stress in high-fat diet-fed rats.
    Ding S; Jiang J; Zhang G; Bu Y; Zhang G; Zhao X
    PLoS One; 2017; 12(8):e0183541. PubMed ID: 28817690
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Redox and non-redox mechanism of in vitro cyclooxygenase inhibition by natural quinones.
    Landa P; Kutil Z; Temml V; Vuorinen A; Malik J; Dvorakova M; Marsik P; Kokoska L; Pribylova M; Schuster D; Vanek T
    Planta Med; 2012 Mar; 78(4):326-33. PubMed ID: 22174077
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biochemical effects of SIRT1 activators.
    Baur JA
    Biochim Biophys Acta; 2010 Aug; 1804(8):1626-34. PubMed ID: 19897059
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The controversial links among calorie restriction, SIRT1, and resveratrol.
    Hu Y; Liu J; Wang J; Liu Q
    Free Radic Biol Med; 2011 Jul; 51(2):250-6. PubMed ID: 21569839
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Resveratrol interferes with AKT activity and triggers apoptosis in human uterine cancer cells.
    Sexton E; Van Themsche C; LeBlanc K; Parent S; Lemoine P; Asselin E
    Mol Cancer; 2006 Oct; 5():45. PubMed ID: 17044934
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases.
    Rao PN; Chen QH; Knaus EE
    J Med Chem; 2006 Mar; 49(5):1668-83. PubMed ID: 16509583
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sirtuin-1 (SIRT1) is required for promoting chondrogenic differentiation of mesenchymal stem cells.
    Buhrmann C; Busch F; Shayan P; Shakibaei M
    J Biol Chem; 2014 Aug; 289(32):22048-62. PubMed ID: 24962570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.